Back to search
FDAFDA · Food and drugs·Recall number D-0463-2022

Medroxyprogesterone Acetate Injection, IM, 150 mg/mL, packaged in 1 ml Single Dose Vial, RX Only, Ideal Pharmacy, 2333 Morris Ave, Union, NJ 07083

Published February 9, 2022 · Recall initiated: December 21, 2021

Summary

FDA records drug Class II recall D-0463-2022, published February 9, 2022 and initiated December 21, 2021. Recalling firm: Ideal Specialty Apothecary, Inc. dba Ideal Pharmacy; Status: Ongoing; Reported quantity: 57,994 vials; Lot: All lots within expiry. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Ideal Specialty Apothecary, Inc. dba Ideal Pharmacy
Distributor
nationwide in the USA
Lot
All lots within expiry
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Medroxyprogesterone Acetate Injection, IM, 150 mg/mL, packaged in 1 ml Single Dose Vial, RX Only, Ideal Pharmacy, 2333 Morris Ave, Union, NJ 07083 recalled?

Yes. FDA published recall D-0463-2022 on February 9, 2022. Reported hazard: Lack of Assurance of Sterility

What should I do if I have this product?

Voluntary: Firm initiated · Letter